Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
24.89
+0.83 (3.45%)
Mar 4, 2025, 11:47 AM EST - Market open
Apellis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -197.88 | -528.63 | -652.17 | -746.35 | -344.87 | Upgrade
|
| Depreciation & Amortization | 1.8 | 1.78 | 1.55 | 1.49 | 0.86 | Upgrade
|
| Other Amortization | 1.56 | 0.3 | 0.46 | 0.96 | 15.54 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.12 | - | - | - | Upgrade
|
| Stock-Based Compensation | 114.13 | 105.95 | 91.09 | 70.67 | 45.38 | Upgrade
|
| Other Operating Activities | 10.89 | 26 | 61.09 | 203.63 | 103.03 | Upgrade
|
| Change in Accounts Receivable | -58.48 | -198.72 | 2.38 | -10.1 | - | Upgrade
|
| Change in Inventory | -10.76 | -60.65 | -69.4 | -16.32 | - | Upgrade
|
| Change in Accounts Payable | 1.09 | 0.17 | 18.69 | 10.49 | -0.05 | Upgrade
|
| Change in Other Net Operating Assets | 49.79 | 58.94 | 32.57 | -77.59 | 19.64 | Upgrade
|
| Operating Cash Flow | -87.87 | -594.74 | -513.75 | -563.13 | -160.49 | Upgrade
|
| Capital Expenditures | -0.4 | -0.77 | -1.52 | -1.1 | -5.42 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.1 | - | - | - | Upgrade
|
| Investment in Securities | - | - | 61.42 | 248.72 | -311.57 | Upgrade
|
| Investing Cash Flow | -0.4 | -0.67 | 59.89 | 247.62 | -316.99 | Upgrade
|
| Long-Term Debt Issued | 365.45 | - | - | - | 322.87 | Upgrade
|
| Net Debt Issued (Repaid) | 365.45 | - | - | - | 322.87 | Upgrade
|
| Issuance of Common Stock | 18.83 | 461.04 | 405.84 | 398.02 | 392.42 | Upgrade
|
| Repurchase of Common Stock | -0.06 | -11.04 | -5.68 | -1.79 | - | Upgrade
|
| Other Financing Activities | -234.98 | -55.5 | -34.5 | -4 | -23.11 | Upgrade
|
| Financing Cash Flow | 149.24 | 394.5 | 365.66 | 392.24 | 692.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.66 | 0.14 | -0.49 | -2.02 | 0.36 | Upgrade
|
| Net Cash Flow | 60.31 | -200.78 | -88.68 | 74.71 | 215.06 | Upgrade
|
| Free Cash Flow | -88.27 | -595.51 | -515.27 | -564.23 | -165.91 | Upgrade
|
| Free Cash Flow Margin | -11.30% | -150.16% | -683.18% | -847.66% | -66.19% | Upgrade
|
| Free Cash Flow Per Share | -0.71 | -5.02 | -4.86 | -6.68 | -2.21 | Upgrade
|
| Cash Interest Paid | 29.37 | 3.29 | 5 | 10.27 | 12.93 | Upgrade
|
| Cash Income Tax Paid | 1.65 | -1.76 | 4.92 | 0.05 | 1.65 | Upgrade
|
| Levered Free Cash Flow | -35.7 | -404.84 | -304.6 | -351.61 | -52.88 | Upgrade
|
| Unlevered Free Cash Flow | -12.01 | -386.65 | -284.66 | -344.3 | -49.7 | Upgrade
|
| Change in Net Working Capital | 24.42 | 170.41 | 4.14 | 80.19 | -43.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.